Skip to main content
3SBio Inc. logo

3SBio Inc. — Investor Relations & Filings

Ticker · 1530 ISIN · KYG8875G1029 LEI · 529900P0TQC1E9Y7FN31 HKEX Manufacturing
Open in API
Filings indexed 1,492 across all filing types
Latest filing 2017-06-19 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 1530

About 3SBio Inc.

http://www.3sbio.com

3SBio Inc. is a biopharmaceutical enterprise specializing in the integrated research, development, production, and commercialization of innovative biopharmaceutical products. The company operates as a biotechnology firm, focusing on the discovery, development, manufacture, and marketing of biologics, with a particular emphasis on mammalian cell-based biopharmaceuticals. 3SBio addresses critical medical needs by providing an extensive range of products and services to markets both domestically and internationally.

Recent filings

Filing Released Lang Actions
DATE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is a short announcement from the board of directors stating the date of a board meeting to approve the final results for the fiscal year ended 31 March 2017 and to consider a final dividend. It does not contain any financial data or the actual report but merely announces the meeting date and agenda. The document length is only 1525 characters, which is quite short and fits the pattern of an announcement rather than a full report. According to the rules, such announcements about upcoming board meetings to approve results and dividends are best classified as Regulatory Filings (RNS) because they do not contain the actual financial results or detailed report but are regulatory announcements related to corporate governance and reporting schedules.
2017-06-19 English
VOLUNTARY ANNOUNCEMENT - TPIAO BEING GRANTED AN APPROVAL FOR DRUG CLINICAL TRIALS FOR ADDITIONAL INDICATIONS
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by the board of 3SBio Inc. regarding the approval for drug clinical trials for additional indications. It is a short announcement (3601 characters) and does not contain financial data, detailed financial performance, or regulatory certifications. It is not a report, transcript, or detailed presentation but an announcement of a regulatory approval related to the company's product. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is a regulatory announcement about a clinical trial approval, which is best classified under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2017-06-09 English
VOLUNTARY ANNOUNCEMENT - EPIAO RECEIVED MARKETING AUTHORIZATION TO LAUNCH FROM PIC/S MEMBER UKRAINE
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by the board of directors of 3SBio Inc. regarding the receipt of marketing authorization for a product (EPIAO) from the Ministry of Health of Ukraine, a PIC/S member. It discusses regulatory approval and market expansion but does not contain financial statements, detailed financial performance, or management discussion of financial results. The document is relatively short (3497 characters) and serves as an announcement of a regulatory milestone rather than a financial report or detailed investor presentation. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Investor Presentation. It is not a voting result, board change, or legal proceeding. The content is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit other specific categories.
2017-06-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2017
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/05/2017 and submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related transactions during the month. The content focuses on share capital changes and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting monthly share capital movements to the exchange, not a financial report or announcement of voting results. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2017-06-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2017
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and details movements in authorised and issued share capital for the month ended 31/05/2017. It includes tables showing share capital balances, share options, warrants, convertibles, and other share issuance or repurchase activities. There is no financial performance data, earnings information, or management discussion. The document is a regulatory filing reporting monthly share capital movements to the Hong Kong Exchanges and Clearing Limited. It is not an annual or interim report, earnings release, or management report. It is a specific regulatory disclosure about share capital changes, fitting the category of Share Issue/Capital Change (SHA). The document length is sufficient and contains substantive data on share capital changes, not merely an announcement or certification, so it is not RPA or RNS.
2017-06-02 English
VOLUNTARY ANNOUNCEMENT - Right of Distribution and Promotion of New Product
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by 3SBio Inc. regarding a strategic cooperation agreement with Lilly China for the distribution and promotion of insulin products in mainland China. It is an announcement of a business agreement and strategic cooperation, not a financial report, earnings release, or regulatory filing. The document does not contain financial statements, management discussion, voting results, or any regulatory certifications. It is a corporate announcement about a business development and partnership. Therefore, it fits best under the category of a general regulatory announcement or miscellaneous corporate announcement that does not fit other specific categories. According to the classification rules, such announcements are best classified as Regulatory Filings (RNS).
2017-05-16 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.